SALVADORI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 362
EU - Europa 209
AS - Asia 140
Totale 711
Nazione #
US - Stati Uniti d'America 362
IE - Irlanda 78
IT - Italia 76
HK - Hong Kong 51
VN - Vietnam 27
SG - Singapore 26
CN - Cina 21
RU - Federazione Russa 11
KR - Corea 9
SE - Svezia 9
FI - Finlandia 8
UA - Ucraina 7
CH - Svizzera 5
GB - Regno Unito 5
DE - Germania 3
AT - Austria 2
IR - Iran 2
TR - Turchia 2
CZ - Repubblica Ceca 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 711
Città #
Chandler 137
Dublin 78
Hong Kong 48
San Mateo 31
Dong Ket 27
Perugia 23
Altamura 18
Medford 16
Princeton 15
Singapore 15
Lawrence 14
Wilmington 13
Des Moines 12
Los Angeles 10
Beijing 9
Seoul 9
Andover 8
Boardman 8
Rome 7
Saint Petersburg 6
Ashburn 5
Lausanne 5
Bologna 4
Milan 4
Duino-Aurisina 3
Helsinki 3
Arlandastad 2
Brixen 2
Cinisello Balsamo 2
Izmir 2
Massarosa 2
Norwalk 2
Redmond 2
Chiaravalle 1
Clifton 1
Denver 1
Edinburgh 1
Fremont 1
Kiev 1
Lappeenranta 1
Ludwigshafen 1
Luxembourg 1
Nagold 1
Olomouc 1
Osimo 1
Parma 1
Redwood City 1
Stockholm 1
Vienna 1
Totale 558
Nome #
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 70
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 58
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 56
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 47
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 46
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 45
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 43
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 43
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 42
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 41
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 41
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 36
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 35
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 33
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 33
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 24
Clinical correlates of state and trait anxiety in multiple sclerosis 17
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 15
null 13
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 10
Totale 748
Categoria #
all - tutte 3.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 1 0 0 0 0 3 4 4 6 0
2020/202165 1 3 0 0 25 0 1 3 2 0 0 30
2021/2022108 0 22 0 1 2 0 0 32 4 10 19 18
2022/2023353 16 63 5 47 28 42 3 17 116 2 8 6
2023/2024178 11 26 2 11 2 0 49 5 8 16 24 24
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 748